Disease modifying therapies modulate retinal layer atrophy in multiple sclerosis: a longitudinal study

被引：0
|
作者：
Al-Louzi, O. [1 ]
Button, J. [1 ]
Lang, A. [2 ]
Bhargava, P. [1 ]
Newsome, S. [1 ]
Carass, A. [2 ]
Balcer, L. [3 ]
Frohman, E. [4 ]
Prince, J. [2 ]
Calabresi, P. [1 ]
Saidha, S. [1 ]
机构：
[1] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA
[3] NYU, Dept Neurol, New York, NY 10016 USA
[4] Univ Texas Southwestern, Dept Neurol, Dallas, TX USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1009
引用
收藏
页码：514 / 515
页数：2
相关论文
共 50 条
  • [11] Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis
    Sotirchos, Elias S.
    Gonzalez-Caldito, Natalia
    Dewey, Blake E.
    Fitzgerald, Kathryn C.
    Glaister, Jeffrey
    Filippatou, Angeliki
    Ogbuokiri, Esther
    Feldman, Sydney
    Kwakyi, Ohemaa
    Risher, Hunter
    Crainiceanu, Ciprian
    Pham, Dzung L.
    Van Zijl, Peter C.
    Mowry, Ellen M.
    Reich, Daniel S.
    Prince, Jerry L.
    Calabresi, Peter A.
    Saidha, Shiv
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (03) : 312 - 321
  • [12] Disease modifying therapies in multiple sclerosis - Reply
    Goodin, DS
    NEUROLOGY, 2002, 59 (03) : 472 - 473
  • [13] RANKING OF DISEASE -MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS
    Fogarty, E.
    Schmitz, S.
    Walsh, C.
    Barry, M.
    VALUE IN HEALTH, 2015, 18 (07) : A750 - A750
  • [14] Disease modifying therapies for relapsing multiple sclerosis
    Wingerchuk, Dean M.
    Weinshenker, Brian G.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [15] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [16] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [17] Disease-modifying therapies for multiple sclerosis
    John R. Corboy
    Douglas S. Goodin
    Elliot M. Frohman
    Current Treatment Options in Neurology, 2003, 5 (1) : 35 - 54
  • [18] Editorial: Disease modifying therapies in multiple sclerosis
    Bonavita, Simona
    Ghajarzadeh, Mahsa
    Lavorgna, Luigi
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [19] LONGITUDINAL ANALYSIS OF RETINAL AND BRAIN ATROPHY IN MULTIPLE SCLEROSIS
    Altarawneh, Heba
    Petropoulos, Ioannis N.
    Ponirakis, Georgios
    Khan, Adnan
    Gad, Hoda Y.
    Al-Shibani, Fatima
    Rehman, Muhammad H.
    Al-Merekhi, Dhabia
    John, Karen
    El-Sotouhy, Ahmed
    Own, Ahmed
    Shuaib, Ashfaq
    Deleu, Dirk Dirk
    Canibano, Beatriz Carcia
    Akhtar, Naveed
    Malik, Rayaz A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [20] Retinal nerve fibre layer and brain atrophy in relapsing-remitting multiple sclerosis: a longitudinal correlation study
    Bisecco, A.
    Gallo, A.
    Lanza, M.
    Sacco, R.
    Borrelli, S.
    Lavorgna, L.
    Cirillo, M.
    Bonavita, S.
    Esposito, F.
    Tedeschi, G.
    JOURNAL OF NEUROLOGY, 2013, 260 : S106 - S106
12345